Pfizer’s omicron vaccine will be ready in March, CEO says

Pfizer’s COVID-19 vaccine designed to target omicron will be ready in March, Albert Bourla, PhD, the drugmaker’s CEO, told CNBC on Jan. 10.

Advertisement

Pfizer has already begun manufacturing omicron-specific COVID-19 vaccines, Dr. Bourla said.

Dr. Bourla said the vaccine will target other variants. He also told CNBC it is not certain whether an omicron vaccine is necessary or how it will be administered, but Pfizer is producing doses because some countries want the vaccine available as soon as possible.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.